Abstract
5-HT1A receptor plays an important role in the delayed onset of antidepressant action of a class of selective serotonin reuptake inhibitors. Moreover, 5-HT1A receptor levels have been shown to be altered in patients suffering from major depression. In this work, hologram quantitative structure – activity relationship (HQSAR) studies were performed on a series of arylpiperazine compounds presenting affinity to the 5-HT1A receptor. The models were constructed with a training set of 70 compounds. The most significant HQSAR model (q2 = 0.81, r2 = 0.96) was generated using atoms, bonds, connections, chirality, and donor and acceptor as fragment distinction, with fragment size of 6 – 9. Predictions for an external test set containing 20 compounds are in good agreement with experimental results showing the robustness of the model. Additionally, useful information can be obtained from the 2D contribution maps.
Keywords: HQSAR, arylpiperazines, 5-HT1A receptor, SSRIs, drug design
Medicinal Chemistry
Title: Two-Dimensional QSAR Studies on Arylpiperazines as High-Affinity 5-HT1A Receptor Ligands
Volume: 4 Issue: 4
Author(s): Karen C. Weber, Kathia M. Honorio, Adriano D. Andricopulo and Alberico B. F. Da Silva
Affiliation:
Keywords: HQSAR, arylpiperazines, 5-HT1A receptor, SSRIs, drug design
Abstract: 5-HT1A receptor plays an important role in the delayed onset of antidepressant action of a class of selective serotonin reuptake inhibitors. Moreover, 5-HT1A receptor levels have been shown to be altered in patients suffering from major depression. In this work, hologram quantitative structure – activity relationship (HQSAR) studies were performed on a series of arylpiperazine compounds presenting affinity to the 5-HT1A receptor. The models were constructed with a training set of 70 compounds. The most significant HQSAR model (q2 = 0.81, r2 = 0.96) was generated using atoms, bonds, connections, chirality, and donor and acceptor as fragment distinction, with fragment size of 6 – 9. Predictions for an external test set containing 20 compounds are in good agreement with experimental results showing the robustness of the model. Additionally, useful information can be obtained from the 2D contribution maps.
Export Options
About this article
Cite this article as:
Weber C. Karen, Honorio M. Kathia, Andricopulo D. Adriano and Da Silva B. F. Alberico, Two-Dimensional QSAR Studies on Arylpiperazines as High-Affinity 5-HT1A Receptor Ligands, Medicinal Chemistry 2008; 4 (4) . https://dx.doi.org/10.2174/157340608784872325
DOI https://dx.doi.org/10.2174/157340608784872325 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Resisting the Resistance in Cancer: Cheminformatics Studies on Short- Path Base Excision Repair Pathway Antagonists Using Supervised Learning Approaches
Combinatorial Chemistry & High Throughput Screening Are the Long-Acting Intramuscular Formulations of Risperidone or Paliperidone Palmitate Associated with Post-Injection Delirium/Sedation Syndrome? An Assessment of Safety Databases
Current Drug Safety The Control of Dopamine Neuron Development, Function and Survival: Insights From Transgenic Mice and The Relevance to Human Disease
Current Medicinal Chemistry Plasma Clusterin Levels and the rs11136000 Genotype in Individuals with Mild Cognitive Impairment and Alzheimer’s Disease
Current Alzheimer Research Recent Scientific Advances Towards the Development of Tendon Healing Strategies
Current Tissue Engineering (Discontinued) Bone Marrow Microenvironment: A Newly Recognized Target for Diabetes- Induced Cellular Damage
Endocrine, Metabolic & Immune Disorders - Drug Targets Overlap between ADHD and Autism - Clinical and Genetic Evidence
Current Psychiatry Reviews Borderline Personality Disorder in Young People and the Prospects for Prevention and Early Intervention
Current Psychiatry Reviews Phage Display as a Tool for Protease Ligand Discovery
Current Pharmaceutical Biotechnology Activation of Melanocortin-4 Receptor by a Synthetic Agonist Inhibits Ethanolinduced Neuroinflammation in Rats
Current Pharmaceutical Design Regulatory Light Chains of Striated Muscle Myosin. Structure, Function and Malfunction
Current Drug Targets - Cardiovascular & Hematological Disorders Neuroimaging Findings Related to Behavioral Disturbances in Alzheimer's Disease: A Systematic Review
Current Alzheimer Research Gut-Brain Axis and Metabolism in Polycystic Ovary Syndrome
Current Pharmaceutical Design Targeting the Cancer Biomarker CD47: A Review on the Diverse Mechanisms of the CD47 Pathway in Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Echocardiographic Hemodynamic Monitoring in the Critically Ill Patient
Current Cardiology Reviews Anticholinesterase and Antioxidant Activities of Spilanthes filicaulis Whole Plant Extracts for the Management of Alzheimer’s Disease
Current Enzyme Inhibition Scyphomedusae of the Mediterranean: State of the Art and Future Perspectives
Central Nervous System Agents in Medicinal Chemistry Meet Our Editorial Board Member
Current Neuropharmacology Antioxidant Therapy for Prevention of Inflammation, Ischemic Reperfusion Injuries and Allograft Rejection
Cardiovascular & Hematological Agents in Medicinal Chemistry Specific Immune Intervention with Monoclonal Antibodies for the Treatment of Multiple Sclerosis
Current Medicinal Chemistry